Translated Titles

A Revolutionary Method for Disease Pathways Identification Using Myocardial Infarction Cross-Platform Data





Key Words

基因調控網路 ; 路徑分析 ; Gene Network ; Pathway Analysis



Volume or Term/Year and Month of Publication


Academic Degree Category




Content Language


Chinese Abstract


English Abstract

Since the day we were born, we have been afflicted with all kinds of illness and diseases. To reduce the pain and fear, all kinds of approaches to attack diseases have been developed. From the aspect of genetics studies, the researchers used to work on a couple of genes that might relate to diseases in all their scientific life. However, along with the advance of biotechnology, we are able to trace and monitor the alteration of gene expression in a whole-genome scale. Furthermore, the chances are the approaches have been moved from individual gene studies to gene-gene interactions and even the gene network, as it is believed that genes are collaboratively functioning in groups instead of working by themselves alone. Therefore, pathway analysis has been getting more attention recently. However, the pathway analysis used update exists many unsolved issues, most importantly, it lacks the integrity of whole-genome regulated networks that actually reflect the gene reaction pathways. We develop a method to identify “Disease-associated Pathways”. Here in this study, we will (1) develop a regulatory gene network by combining each gene-gene reaction pair, (2) identify the shortest pathways from a whole genome network, (3) establish pathway analysis algorithms to calculate the full pathway expression value, and (4) distinguish the disease and non-disease pathways by incorporating microarray data. The purpose of this pipe-line approach is to quest for disease-associated pathways and by unveiling the pathways, it will also provide a better choice for drug target in pharmaceutical industry in the near future.

Topic Category 基礎與應用科學 > 資訊科學
醫藥衛生 > 醫藥總論
醫學科技學院 > 醫學資訊研究所
  1. 1.(2006) The Gene Ontology (GO) project in 2006. Nucleic Acids Res 34: D322-326
  2. 2.(2008) The Gene Ontology project in 2008. Nucleic Acids Res 36: D440-444
  3. 3.Alvo M, Liu Z, Williams A, Yauk C (2010) Testing for mean and correlation changes in microarray experiments: an application for pathway analysis. BMC Bioinformatics 11: 60
  4. 4.Chen L, Xuan J, Gu J, Wang Y, Zhang Z, Wang TL, Shih leM (2012) Integrative network analysis to identify aberrant pathway networks in ovarian cancer. Pac Symp Biocomput 2012:31-42
  5. 5.Fang Z, Tian W, Ji H, (2011) A network-based gene-weighting approach for pathway analysis. Cell Res. 2011 Sep 6. doi:10.1038/cr.2011.149.
  6. 6.Chuang HY, Lee E, Liu YT, Lee D, Ideker T (2007) Network-based classification of breast cancer metastasis. Mol Syst Biol 3: 140
  7. 8.Faust K, Dupont P, Callut J, van Helden J (2010) Pathway discovery in metabolic networks by subgraph extraction. Bioinformatics 26: 1211-1218
  8. 9.Fayard E, Xue G, Parcellier A, Bozulic L, Hemmings BA (2010) Protein Kinase B (PKB/Akt), a Key Mediator of the PI3K Signaling Pathway. Curr Top Microbiol Immunol
  9. 10.Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M (2010) KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 38: D355-360
  10. 11.Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, Kawashima S, Katayama T, Araki M, Hirakawa M (2006) From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 34: D354-357
  11. 12.Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M (2004) The KEGG resource for deciphering the genome. Nucleic Acids Res 32: D277-280
  12. 13.Krull M, Pistor S, Voss N, Kel A, Reuter I, Kronenberg D, Michael H, Schwarzer K, Potapov A, Choi C, Kel-Margoulis O, Wingender E (2006) TRANSPATH: an information resource for storing and visualizing signaling pathways and their pathological aberrations. Nucleic Acids Res 34: D546-551
  13. 14.Sanders P. (2009) Fast Route Planning. YouTube.
  14. 15.Tanikawa C, Ri C, Kumar V, Nakamura Y, Matsuda K (2010) Crosstalk of EDA-A2/XEDAR in the p53 signaling pathway. Mol Cancer Res 8: 855-863
  15. 17.W. DE. (1959) A note on two problems in connexion with graphs. Numerische Mathematlk, pp. 269 - 271.
  16. 19.Hall, JL, Grindle S, Han X, Fermin D, Park S, Chen Y, Bache RJ, Mariash A, Guan Z, Ormaza S, Thompson J, Graziano J, Sam Lazaro SE, Pan S, 20.Simari RD, Miller LW. (2004) Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks. Physiol Genomics 17, 283-291.
  17. 21.Strom CC, Aplin M, Ploug T, Christoffersen TE, Langfort J, Viese M, Galbo H, Haunso S, Sheikh SP(2005).Expression profiling reveals differences in metabolic gene expression between
  18. 22.Tarnavski O, McMullen JR, Schinke M, Nie Q, Kong S, Izumo S (2004). Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. Physiol Genomics 16: 349-360.
  19. 23.Matsumoto Y, Tsukada Y, Miyakoshi A, Sakuma H, Kohyama K. C protein-induced myocarditis and subsequent dilated cardiomyopathy: rescue from death and prevention of dilated cardiomyopathy by chemokine receptor DNA therapy. J Immunol 2004 Sep 01;173(5):3535-41.
  20. 24.Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 2009 Feb 01;30(2):85-94.
  21. 25.Wei JQ, Shehadeh LA, Mitrani JM, Pessanha M, Slepak TI, Webster KA, Bishopric NH. Quantitative Control of Adaptive Cardiac Hypertrophy by Acetyltransferase p300. Circulation 2008 Aug 26;118(9):934-46.
  22. 26.Liu Q, Chen X, Macdonnell SM, Kranias EG, Lorenz JN, Leitges M, Houser SR, Molkentin JD. Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach. Circ Res 2009 Jul 17;105(2):194-200.
  23. 28.Liu Q, Chen X, Macdonnell SM, Kranias EG, Lorenz JN, Leitges M, Houser SR, Molkentin JD. Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach. Circ Res 2009 Jul 17;105(2):194-200.
  24. 29.Morimoto H, Takahashi M, Shiba Y, Izawa A, Ise H, Hongo M, Hatake K, Motoyoshi K, Ikeda U. Bone Marrow-Derived CXCR4+ Cells Mobilized by Macrophage Colony-Stimulating Factor Participate in the Reduction of Infarct Area and Improvement of Cardiac Remodeling after Myocardial Infarction in Mice. Am J Pathol 2007 Sep 01;171(3):755-66.
  25. 7.Endy D, Brent R (2001) Modelling cellular behaviour. Nature 409: 391-395
  26. 16.Thomas H. Cormen CEL, Ronald L. Rivest. (2001) Introduction to Algorithms. In Leiserson CE (ed.), pp. Section 22.23: Depth-first search, pp. 540–549.
  27. 18.Braunwald, E. (Ed.). (1992). Heart disease: A textbook of cardiovascular medicine (4th ed., pp.1200-1222). Philadephia, PA: W. B. Saunders Company
  28. 27.Braz JC, Gregory K, Pathak A, Zhao W, Sahin B, Klevitsky R, Kimball TF, Lorenz JN, Nairn AC, Liggett SB, Bodi I, Wang S, Schwartz A, Lakatta EG, DePaoli-Roach AA, Robbins J, Hewett TE, Bibb JA, Westfall MV, Kranias EG, Molkentin JD. PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med 2004 Mar 01;10(3):248-54.
  29. 30.戴政. (2000) 生物醫學統計概論. pp. P.235-P.241.
  30. 31.沈明來. (1997) 實用無母數統計學與計數資料分析. pp. p.292- p.297.